On September 2, 2021 Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) reported that management will present a company overview at the following virtual investor conferences (Press release, Ionis Pharmaceuticals, SEP 2, 2021, View Source [SID1234587210]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021
Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021
Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company’s website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

On September 2, 2021 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported it will participate in three upcoming conferences (Press release, Delcath Systems, SEP 2, 2021, View Source [SID1234595224]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021

Presentation Date and Time: On-demand beginning 9/13/2021 at 7:00 AM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23

Presentation Date and Time: 9/21/2021 12:25 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Cantor Fitzgerald Healthcare Conference: September 27th to 30th, 2021

Presentation Date and Time: 9/29/2021 4:40 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].

On September 2, 2021 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, reported that the Company will participate in Wells Fargo’s Virtual Healthcare Conference and H.C. Wainwright’s 23rd Annual Global Investment Conference being held virtually (Press release, Infinity Pharmaceuticals, SEP 2, 2021, View Source [SID1234587159]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details can be found below:

Wells Fargo Virtual Healthcare Conference
Format: Fireside chat and 1-on-1 meetings
Date and Time: Fireside chat September 9 th at 2:40pm ET; 1-on-1 meetings September 9-10
Webcast Link: View Source
H.C. Wainwright Virtual 23rd Annual Global Investment Conference
Format: On demand presentation and 1-on-1 meetings
Date and Time: Presentation available Monday, September 13 th 7am ET; 1-on-1 meetings September 13-15
Registration Link
The presentations and archived webcasts can be accessed in the Investors/Media section of Infinity’s website at www.infi.com and will be available on Infinity’s website for 30 days following the event.

On September 2, 2021 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported that Raul Rodriguez, the company’s president and chief executive officer, and Dean Schorno, the company’s chief financial officer, will participate in the following virtual investor conferences in September (Press release, Rigel, SEP 2, 2021, View Source [SID1234587176]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Biopharma Conference (September 8-10, 2021)

Raul Rodriguez will participate in a panel discussion entitled: "Sickle Cell, Beta-Thal, ITP & PKD – Measuring Industry Progress in Benign Hematology" on Friday, September 10th at 12:30 p.m. ET.
H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)

Dean Schorno will present a company overview, which will be available for on-demand viewing for conference attendees starting on Monday, September 13th at 7:00 a.m. ET.
Cantor Fitzgerald Global Healthcare Conference (September 27-30, 2021)

Raul Rodriguez will present a company overview on Tuesday, September 28th at 4:40 p.m. ET.
To access the live webcast of the Citi Annual Biopharma Conference panel and the Cantor Fitzgerald Global Healthcare Conference presentation, go to the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

On September 2, 2021 Novocure (NASDAQ: NVCR) reported that Ashley Cordova, Chief Financial Officer, and Pritesh Shah, Chief Commercial Officer, will participate in the 2021 Wells Fargo Virtual Healthcare Conference on September 10, 2021 (Press release, NovoCure, SEP 2, 2021, View Source [SID1234587195]). Ms. Cordova and Mr. Shah will take part in a fireside chat at 10:40 a.m. EDT. Ms. Cordova and Mr. Shah will also participate in one-on-one meetings with investors throughout the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation can be accessed from the Investor Relations page of Novocure’s website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event.

Novocure’s corporate presentation is updated periodically, and the current presentation can be accessed from the Investor Relations page of Novocure’s website, www.novocure.com/investor-relations. Novocure has used, and intends to continue to use, its Investor Relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.